AstraZeneca confirmed that early data from a small trial, first reported by the Financial Times, had shown limited efficacy for the vaccine against mild disease primarily due to this variant.
Read more here:: Post India Listing
Related Posts
Ahmedabad to host pink ball Test vs Eng: Ganguly
- India-Blog-News-Service
- October 20, 2020
- 0
Ahmedabad will host the day-night pink ball Test during England’s big-ticket tour of India early next year, BCCI president Sourav Ganguly said on Tuesday. England […]
Lakhimpur Kheri violence LIVE Updates: SP chief Akhilesh Yadav to meet families of deceased farmers today
- India-Blog-News-Service
- October 6, 2021
- 0
Lakhimpur Kheri violence LIVE: Akhilesh Yadav to meet families of deceased farmers today Read more here:: India News Listing
Coronavirus | Karnataka not using Covaxin for those on immunosuppressants
- India-Blog-News-Service
- February 17, 2021
- 0
This is one of the contraindications mentioned by makers of the vaccine Read more here:: Post India Listing